Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-06-25 17:10 CEST (UTC+2h)

CFDA: Draft guidance? [RSABE / ABEL]

posted by libaiyi - China, 2018-06-13 03:39  - Posting: # 18895
Views: 385

Thanks for you reply.

Another question,
how to write the null hypothesis and alternative hypothesis for BE based on FDA or EMA method?

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,428 posts in 3,913 threads, 1,176 registered users;
online 32 (0 registered, 32 guests [including 22 identified bots]).

Lack of clarity is always a sign of dishonesty.    Celia Green

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed